Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Sep;43(9):703–709. doi: 10.1136/jcp.43.9.703

Guidelines on the investigation and management of thrombophilia. The British Committee for Standards in Haematology.

PMCID: PMC502744  PMID: 2212062

Full text

PDF
703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann F., Kruithof I. E. Tissue plasminogen activator: chemical and physiological aspects. Semin Thromb Hemost. 1984 Jan;10(1):6–17. doi: 10.1055/s-2007-1004403. [DOI] [PubMed] [Google Scholar]
  2. Bauer K. A., Rosenberg R. D. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood. 1987 Aug;70(2):343–350. [PubMed] [Google Scholar]
  3. Bertina R. M., Broekmans A. W., Krommenhoek-van Es C., van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemost. 1984 Feb 28;51(1):1–5. [PubMed] [Google Scholar]
  4. Bertina R. M., van Wijngaarden A., Reinalda-Poot J., Poort S. R., Bom V. J. Determination of plasma protein S--the protein cofactor of activated protein C. Thromb Haemost. 1985 Apr 22;53(2):268–272. [PubMed] [Google Scholar]
  5. Bertina R. M., van der Linden I. K., Engesser L., Muller H. P., Brommer E. J. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost. 1987 Apr 7;57(2):196–200. [PubMed] [Google Scholar]
  6. Boerger L. M., Morris P. C., Thurnau G. R., Esmon C. T., Comp P. C. Oral contraceptives and gender affect protein S status. Blood. 1987 Feb;69(2):692–694. [PubMed] [Google Scholar]
  7. Broekmans A. W. Hereditary protein C deficiency. Haemostasis. 1985;15(4):233–240. doi: 10.1159/000215154. [DOI] [PubMed] [Google Scholar]
  8. Cohen H., Mackie I. J., Walshe K., Gillmer M. D., Machin S. J. A comparison of the effects of two triphasic oral contraceptives on haemostasis. Br J Haematol. 1988 Jun;69(2):259–263. doi: 10.1111/j.1365-2141.1988.tb07631.x. [DOI] [PubMed] [Google Scholar]
  9. Comp P. C., Thurnau G. R., Welsh J., Esmon C. T. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986 Oct;68(4):881–885. [PubMed] [Google Scholar]
  10. Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J. 1983 Mar 1;209(3):847–856. doi: 10.1042/bj2090847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dolan G., Greaves M., Cooper P., Preston F. E. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol. 1988 Dec;70(4):417–421. doi: 10.1111/j.1365-2141.1988.tb02510.x. [DOI] [PubMed] [Google Scholar]
  12. Grimaudo V., Gueissaz F., Hauert J., Sarraj A., Kruithof E. K., Bachmann F. Necrosis of skin induced by coumarin in a patient deficient in protein S. BMJ. 1989 Jan 28;298(6668):233–234. doi: 10.1136/bmj.298.6668.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworth-Young C. G., Loizou S., Hughes G. R. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. doi: 10.1016/s0140-6736(83)91267-9. [DOI] [PubMed] [Google Scholar]
  14. Harris E. N. Syndrome of the black swan. Br J Rheumatol. 1987 Oct;26(5):324–326. doi: 10.1093/rheumatology/26.5.324. [DOI] [PubMed] [Google Scholar]
  15. Juhan-Vague I., Valadier J., Alessi M. C., Aillaud M. F., Ansaldi J., Philip-Joet C., Holvoet P., Serradimigni A., Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost. 1987 Feb 3;57(1):67–72. [PubMed] [Google Scholar]
  16. Lane D. A., Flynn A., Ireland H., Erdjument H., Samson D., Howarth D., Thompson E. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin. Br J Haematol. 1987 Apr;65(4):451–456. doi: 10.1111/j.1365-2141.1987.tb04149.x. [DOI] [PubMed] [Google Scholar]
  17. Lane D. A., Lowe G. D., Flynn A., Thompson E., Ireland H., Erdjument H. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Br J Haematol. 1987 Aug;66(4):523–527. doi: 10.1111/j.1365-2141.1987.tb01338.x. [DOI] [PubMed] [Google Scholar]
  18. Lottenberg R., Dolly F. R., Kitchens C. S. Recurring thromboembolic disease and pulmonary hypertension associated with severe hypoplasminogenemia. Am J Hematol. 1985 Jun;19(2):181–193. doi: 10.1002/ajh.2830190211. [DOI] [PubMed] [Google Scholar]
  19. Mahasandana C., Suvatte V., Marlar R. A., Manco-Johnson M. J., Jacobson L. J., Hathaway W. E. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet. 1990 Jan 6;335(8680):61–62. doi: 10.1016/0140-6736(90)90201-f. [DOI] [PubMed] [Google Scholar]
  20. Mannucci P. M., Kluft C., Traas D. W., Seveso P., D'Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol. Br J Haematol. 1986 Aug;63(4):753–759. doi: 10.1111/j.1365-2141.1986.tb07559.x. [DOI] [PubMed] [Google Scholar]
  21. Mannucci P. M., Tripodi A. Inherited factors in thrombosis. Blood Rev. 1988 Mar;2(1):27–35. doi: 10.1016/0268-960x(88)90005-7. [DOI] [PubMed] [Google Scholar]
  22. Mannucci P. M., Viganò S., Bottasso B., Candotti G., Bozzetti P., Rossi E., Pardi G. Protein C antigen during pregnancy, delivery and puerperium. Thromb Haemost. 1984 Oct 31;52(2):217–217. [PubMed] [Google Scholar]
  23. Marciniak E., Wilson H. D., Marlar R. A. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood. 1985 Jan;65(1):15–20. [PubMed] [Google Scholar]
  24. McGehee W. G., Klotz T. A., Epstein D. J., Rapaport S. I. Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med. 1984 Jul;101(1):59–60. doi: 10.7326/0003-4819-101-1-59. [DOI] [PubMed] [Google Scholar]
  25. Miletich J., Sherman L., Broze G., Jr Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987 Oct 15;317(16):991–996. doi: 10.1056/NEJM198710153171604. [DOI] [PubMed] [Google Scholar]
  26. Odegård O. R., Abildgaard U. Antithrombin III: critical review of assay methods. Significance of variations in health and disease. Haemostasis. 1978;7(2-3):127–134. doi: 10.1159/000214249. [DOI] [PubMed] [Google Scholar]
  27. Rosenberg R. D. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975 Jan 16;292(3):146–151. doi: 10.1056/NEJM197501162920307. [DOI] [PubMed] [Google Scholar]
  28. Sanal S. O., Buckley R. H. Antibody-dependent cellular cytotoxicity in primary immunodeficiency diseases and with normal leukocyte subpopulations. Importance of the type of target. J Clin Invest. 1978 Jan;61(1):1–10. doi: 10.1172/JCI108907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Seligsohn U., Berger A., Abend M., Rubin L., Attias D., Zivelin A., Rapaport S. I. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med. 1984 Mar 1;310(9):559–562. doi: 10.1056/NEJM198403013100904. [DOI] [PubMed] [Google Scholar]
  30. Thaler E., Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981 Jun;10(2):369–390. [PubMed] [Google Scholar]
  31. Tomonaga M., Yoshida Y., Tagawa M., Jinnai I., Kuriyama K., Amenomori T., Yoshioka A., Matsuo T., Nonaka H., Ichimaru M. Cytochemistry of acute promyelocytic leukemia (M3): leukemic promyelocytes exhibit heterogeneous patterns in cellular differentiation. Blood. 1985 Aug;66(2):350–357. [PubMed] [Google Scholar]
  32. Vikydal R., Korninger C., Kyrle P. A., Niessner H., Pabinger I., Thaler E., Lechner K. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism. Thromb Haemost. 1985 Dec 17;54(4):744–745. [PubMed] [Google Scholar]
  33. Walker F. J. Protein S and the regulation of activated protein C. Semin Thromb Hemost. 1984 Apr;10(2):131–138. doi: 10.1055/s-2007-1004415. [DOI] [PubMed] [Google Scholar]
  34. Weenink G. H., Treffers P. E., Kahlé L. H., ten Cate J. W. Antithrombin III in normal pregnancy. Thromb Res. 1982 May 15;26(4):281–287. doi: 10.1016/0049-3848(82)90293-6. [DOI] [PubMed] [Google Scholar]
  35. Wiman B., Ljungberg B., Chmielewska J., Urdén G., Blombäck M., Johnsson H. The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med. 1985 Feb;105(2):265–270. [PubMed] [Google Scholar]
  36. Wohl R. C., Summaria L., Chediak J., Rosenfeld S., Robbins K. C. Human plasminogen variant Chicago III. Thromb Haemost. 1982 Oct 29;48(2):146–152. [PubMed] [Google Scholar]
  37. Wohl R. C., Summaria L., Robbins K. C. Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II. J Biol Chem. 1979 Sep 25;254(18):9063–9069. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES